PMCF on Safety and Performance of HiResTM Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss - Trial NCT04610112
Access comprehensive clinical trial information for NCT04610112 through Pure Global AI's free database. This phase not specified trial is sponsored by Advanced Bionics AG and is currently Recruiting. The study focuses on Cochlear Hearing Loss. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Advanced Bionics AG
Timeline & Enrollment
N/A
Sep 16, 2020
May 31, 2022
Primary Outcome
Speech recognition score (word score),Analysis of participants with device failure
Summary
This is a prospective study designed to evaluate the safety and performance of the HiResTM
 Ultra Cl HiFocusTM MS Electrode and HiResTM Ultra 3D Cl HiFocusTM MS Electrode (Ultra X)
 under normal conditions of use as it is approved for this device.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04610112
Device Trial